RPG Life Sciences Limited

Key metrics

Price as of 2026-07-17

Stock price

₹2859.80

Market cap

4,729 Cr

Stock P/E

42.6

P/B

7.81

Dividend yield

0.8%

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly · ₹ Cr · tap + rows to expand

Metric	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026
Sales	143 Cr	169 Cr	182 Cr	180 Cr	177 Cr
Operating expenses (approx.)	3 Cr	128 Cr	127 Cr	145 Cr	131 Cr
EBITDA	140 Cr	41 Cr	55 Cr	35 Cr	46 Cr
OPM %	98.2%	24.1%	30.2%	19.3%	26.2%
Other income	5 Cr	5 Cr	5 Cr	3 Cr	12 Cr
Interest	0.18 Cr	0.13 Cr	0.12 Cr	0.25 Cr	0.39 Cr
Depreciation	5 Cr	5 Cr	5 Cr	5 Cr	6 Cr
Profit before tax	135 Cr	35 Cr	49 Cr	29 Cr	40 Cr
Tax %	13.0%	25.8%	25.5%	24.0%	25.6%
Net profit	117 Cr	26 Cr	37 Cr	22 Cr	30 Cr
EPS (₹)	₹70.96	₹15.90	₹22.28	₹13.38	₹18.08

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2025	Mar 2026	TTM
Sales	653 Cr	708 Cr	Sign in for TTM
Operating expenses (approx.)	398 Cr	531 Cr	Sign in for TTM
EBITDA	255 Cr	177 Cr	Sign in for TTM
OPM %	39.0%	25.0%	Sign in for TTM
Other income	13 Cr	26 Cr	Sign in for TTM
Interest	0.62 Cr	0.89 Cr	Sign in for TTM
Depreciation	21 Cr	21 Cr	Sign in for TTM
Profit before tax	233 Cr	154 Cr	Sign in for TTM
Tax %	21.3%	25.3%	Sign in for TTM
Net profit	183 Cr	115 Cr	Sign in for TTM
EPS (₹)	₹110.80	₹18.08	Sign in for TTM
Dividend payout %	14.4%	34.5%	Sign in for TTM

Trailing twelve months totals and margin rows

Annual · ₹ Cr · tap + rows to expand

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2025	Mar 2026
Cash from operating activity	78 Cr	57 Cr
Cash from investing	-42 Cr	86 Cr
Cash from financing	-27 Cr	-21 Cr
Net cash flow	9 Cr	122 Cr
Free cash flow (OCF − Capex)	42 Cr	-9 Cr

Ratios as reported or derived per annual period.

Loading peers…